Moderna-Merck mRNA Cancer Vaccine Shows Durable Melanoma Responses
The personalized mRNA cancer vaccine mRNA-4157 combined with Keytruda continues to show improved recurrence-free survival in high-risk melanoma. mRNA oncology is no longer theoretical.
Mar 20, 2026 · 6 min read